olaparib
Olaparib is a compound that functions as a poly(ADP-ribose) polymerase (PARP) inhibitor, used in pharmaceutical manufacturing. It is a member of the N-acylpiperazine class and is employed as an antineoplastic agent, specifically as an apoptosis inducer via inhibition of NAD(+) ADP-ribosyltransferase.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 763113-22-0
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate
4-{[4-fluoro-3-(piperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate for olaparib synthesis
4-{[4-fluoro-3-(4-nitrosopiperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
nitrosamine impurity reference standard
DL-Methamphetamine
active pharmaceutical ingredient
2,4-Quinazolinediamine, N2-(3-aminopropyl)-6,7-dimethoxy-N2-methyl-
alfuzosin related substance impurity
Enalaprilat
active pharmaceutical ingredient
N-((1R)-1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-L-proline
active pharmaceutical ingredient
4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
FDLYAMZZIXQODN-UHFFFAOYSA-N
C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F